Amedisys Inc (AMED)
95.46
-0.25
(-0.26%)
USD |
NASDAQ |
May 15, 15:26
Amedisys Price to Book Value: 2.867 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 14, 2024 | 2.874 |
May 13, 2024 | 2.865 |
May 10, 2024 | 2.868 |
May 09, 2024 | 2.839 |
May 08, 2024 | 2.825 |
May 07, 2024 | 2.774 |
May 06, 2024 | 2.773 |
May 03, 2024 | 2.765 |
May 02, 2024 | 2.776 |
May 01, 2024 | 2.759 |
April 30, 2024 | 2.764 |
April 29, 2024 | 2.758 |
April 26, 2024 | 2.756 |
April 25, 2024 | 2.737 |
April 24, 2024 | 2.734 |
April 23, 2024 | 2.737 |
April 22, 2024 | 2.740 |
April 19, 2024 | 2.715 |
April 18, 2024 | 2.726 |
April 17, 2024 | 2.731 |
April 16, 2024 | 2.740 |
April 15, 2024 | 2.743 |
April 12, 2024 | 2.760 |
April 11, 2024 | 2.771 |
April 10, 2024 | 2.771 |
Date | Value |
---|---|
April 09, 2024 | 2.784 |
April 08, 2024 | 2.774 |
April 05, 2024 | 2.784 |
April 04, 2024 | 2.787 |
April 03, 2024 | 2.781 |
April 02, 2024 | 2.776 |
April 01, 2024 | 2.775 |
March 31, 2024 | |
March 28, 2024 | 2.823 |
March 27, 2024 | 2.832 |
March 26, 2024 | 2.827 |
March 25, 2024 | 2.823 |
March 22, 2024 | 2.823 |
March 21, 2024 | 2.823 |
March 20, 2024 | 2.823 |
March 19, 2024 | 2.842 |
March 18, 2024 | 2.862 |
March 15, 2024 | 2.855 |
March 14, 2024 | 2.842 |
March 13, 2024 | 2.856 |
March 12, 2024 | 2.853 |
March 11, 2024 | 2.858 |
March 08, 2024 | 2.852 |
March 07, 2024 | 2.852 |
March 06, 2024 | 2.849 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.160
Minimum
Mar 23 2023
12.74
Maximum
Jan 25 2021
6.288
Average
5.839
Median
Price to Book Value Benchmarks
Chemed Corp | 7.248 |
Regional Health Properties Inc | -- |
Addus HomeCare Corp | 2.497 |
OptimizeRx Corp | 1.895 |
Option Care Health Inc | 3.624 |
Price to Book Value Related Metrics
PS Ratio | 1.389 |
Price to Free Cash Flow | 34.50 |
Price | 95.46 |
Earnings Yield | -0.67% |
Market Cap | 3.119B |
Operating PE Ratio | 17.11 |
Normalized PE Ratio | 36.18 |